首页> 美国卫生研究院文献>Clinical Epigenetics >Chidamide decitabine cytarabine aclarubicin and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm phase 1/2 study

【2h】

Chidamide decitabine cytarabine aclarubicin and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm phase 1/2 study

机译：茜酰胺去甲脒糖胺血清细胞菌落刺激因子（CDCAG）患者复发/难治性急性髓性白血病：单臂第1/2研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

Patient demographics and baseline characteristics (N = 93)

机译：患者人口统计和基线特征（n = 93）

著录项

期刊名称 Clinical Epigenetics
作者
Lixin Wang; Jianmin Luo; Guofeng Chen; Meiyun Fang; Xudong Wei; Yinghua Li; Zhuogang Liu; Yin Zhang; Sujun Gao; Jianliang Shen; Xin Wang; Xiaoning Gao; Wei Zhou; Yigai Ma; Hui Liu; Xinquan Li; Linhua Yang; Kai Sun; Li Yu;
展开▼
作者单位

展开▼
年(卷),期 2020(-1),-1
年度 2020
页码 -1
总页数 11
原文格式 PDF
正文语种
中图分类遗传学;
关键词

机译：复发/难治性急性髓性白血病;下一代测序;组蛋白脱乙酰化酶抑制剂;DNA甲基转移酶抑制剂;

相似文献

外文文献
中文文献
专利

1. Chidamide, Decitabine, Cytarabine, Aclarubicin, and Granulocyte Colony Stimulating Factor (CDCAG) in Adults with Relapsed/Refractory Acute Myeloid Leukemia: Final Results from a Phase 1/2 Study [J] . Wang Lixin, Chen Guofeng, Shen Jianliang, Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：赤酰胺，薯司，糖醇，Aclarubicin和粒细胞菌落刺激因子（Cdcag）在成人中复发/难治性急性髓性白血病：最终结果来自1/2研究
2. Efficacy and Safety of C-CAG Regimen (cladribine in combination with granulocyte colony-stimulating factor, low-dose cytarabine and aclarubicin) in Patients with Refractory/Relapsed Acute Myeloid Leukemia: A Phase 2, Single Center, Single Arm Study [J] . Wang Hua, Lu Yue Blood: The Journal of the American Society of Hematology . 2018,第NovaelaTreatmentAppr期

机译：C-CAG方案（CLADRIBINE与粒细胞菌落刺激因子，低剂量红细胞和AClarubicin组合）的疗效和安全性在难治性/复发急性髓性白血病患者中：2，单中心，单臂研究
3. Cladribine with Granulocyte Colony-Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study [J] . Hua Wang, Liang Wang, Chun Li, The oncologist . 2020,第11期

机译：用粒细胞菌落刺激因子，糖碱和难治性/复发急性髓鞘白血病中的粒细胞刺激因子，溶细胞素和Aclarubicin方案：II期多中心研究
4. Computationally derived cytological image markers for predicting risk of relapse in acute myeloid leukemia patients following bone marrow transplantation [C] . Sara ArabYarmohammadi, Zelin Zhang, Patrick Leo, Conference on Medical Imaging: Digital Pathology . 2020

机译：计算源自骨髓移植后急性髓性白血病患者复发风险的细胞学图像标志物
5. The Role of Colony-Stimulating Factor 1 and its Receptor on Acute Myeloid Leukemia [D] . Fateen, Mohammed 2012

机译：集落刺激因子1及其受体在急性髓样白血病中的作用
6. Efficacy and safety of decitabine combined with low-dose cytarabine aclarubicin and granulocyte colony-stimulating factor compared with standard therapy in acute myeloid leukemia patients with TP53 mutation [O] . Si-Si Chen, Qian Sun, Lan Cao, 2021

机译：与急性髓白血病患者的TP53突变患者的标准治疗相比Defitabine结合低剂量含有氨基甲酸酯Aclarubicin和粒细胞菌落刺激因子的疗效和安全性
7. Cladribine with Granulocyte Colony‐Stimulating Factor, Cytarabine, and Aclarubicin Regimen in Refractory/Relapsed Acute Myeloid Leukemia: A Phase II Multicenter Study [O] . Hua Wang, Liang Wang, Chun Li, 2020

机译：用粒细胞殖民群刺激因子，糖碱和难治性/复发急性髓鞘细胞蛋白酶的刺激因子，溶氨基胺和Aclarubicin中的菌根：II期多中心研究

Chidamide decitabine cytarabine aclarubicin and granulocyte colony-stimulating factor (CDCAG) in patients with relapsed/refractory acute myeloid leukemia: a single-arm phase 1/2 study

摘要

著录项

相似文献

相关主题

期刊订阅